FRCPath Haem Part 1 MCQ-Gen Haem 398
- amirhayat2527
- 1 day ago
- 0 min read
A 30yr-old pt with PNH is 20 weeks pregnant. She has been on Ravulizumab for the past 12 months. labs: Hb: 88g/L, LDH 600IU and no thrombosis. Best Next step?
Continue Ravulizumab throughout pregnancy
Stop Ravilizumab and manage with transfusion
Switch to Crovalimab
Switch to Eculizumab


Correct Answer: Switch To Eculizumab
Explanation:
Ravulizumab is not recommended in pregnancy due to insufficient safety data. Eculizumab is the preferred C5 inhibitor in pregnant patients with PNH.
In this case:
20 weeks pregnant
Hb 88 g/L
LDH 600 IU/L → ongoing hemolysis
On Ravulizumab
✅ Best Next Step:
Switch from Ravulizumab to eculizumab.
Why?
Eculizumab has established safety data in pregnancy
It reduces maternal thrombosis risk and improves fetal outcomes
Ravulizumab lacks sufficient pregnancy safety evidence
After switching:
Monitor LDH closely
Dose-adjust eculizumab during pregnancy (often requires shorter intervals)